Introduction Hepatitis-associated antigen (H.A.A.) is a marker for the infective agent responsible for long incubation (type B) acute infective hepatitis (Giles et al., 1969; Krugman and Giles, 1970) . Dudley et al. (1972) suggested that the liver cell damage in H.A.A.-positive patients may be related to the thymusdependent (T) lymphocyte cell-mediated immune response against that infective agent. Which clinical course occurs in any H.A.A.-positive patient may then depend on variations in T lymphocyte function. In the presence of normal T lymphocyte function an acute hepatitis will be produced which will resolve completely with clearance of the infective agent. When specific T lymphocyte function against the infective agent is absent both the infective agent and H.A.A. will persist with no evidence of liver cell damage. If T lymphocyte function is impaired an intermediate course will result with incomplete removal of the infective agent and continuing liver cell damage.
After contact with a specific antigen the development of cellmediated immunity to that antigen is dependent on the production of sensitized T lymphocytes which on subsequent exposure to the antigen are capable of recognizing and reacting with it. This lymphocyte-antigen interaction results in the lymphocyte producing a number of soluble factors which result in both the inactivation of antigen and in tissue damage. One of these soluble factors is macrophage migration inhibition factor. Thus the ability of T lymphocytes to produce macrophage migration inhibition factor when incubated with an antigen can be used as an in-vitro index of cell-mediated immunity to that antigen. One such method of detecting the production of macrophage migration inhibition factor by sensitized T lympho- (Gocke and Howe, 1970 ) using standard antibody (Fox et al., 1969) .
Leucocyte Migration.-The method used was as described by Soborg (1971) with minor modifications. A 30-ml sample of venous blood was drawn into plastic disposable syringes containing 600 units of heparin. After mixing with 5 ml of 1% methyl cellulose the blood was allowed to sediment at 370C for 30 minutes. The leucocyte-rich plasma was discharged and the contained cells washed three times in tissue culture medium (TC 199) and resuspended in about 0 5 ml of the same medium. This suspension was aspirated into 14-mm capillary tubes which were then sealed at one end by heating and centrifuged at 3,000 r.p.m. for three minutes. The capillary tubes were then cut 0-5 to 1 mm below the cell fluid interface and the part containing cells were fixed to the bottom of a 0-5-ml culture chamber containing culture medium by silicone wax. The culture medium used consisted of a mixture of human sera and TC 199 in the ratio of 1 to 4. After addition of antigen the chambers were sealed excluding air. Sterile procedure was followed at all times. After incubation at 37°C for 18 hours the sera of leucocyte migration was measured by projection microscopy and paper planimetry. All cultures were performed in triplicate and only accepted if all were within 10% of each other. The average migration areas were calculated and the results expressed as the migration index by dividing the mean area of leucocyte migration in the test chamber containing antigen by the mean area of migration in the control chamber. A migration index between 0-8 and 1 2 represents no detectable cell-mediated immunity to the test antigen. Values less than 0-8 represent inhibition of migration and indicate the presence of cell-mediated immunity to the test antigen. The significance of values greater than 1 2 is not at present clear. (Fig. 3) Changes in Leucocyte Migration after Acute Hepatitis.-Follow-up studies were performed in two patients with uncomplicated acute hepatitis by using autologous serum and liver obtained at the time of hepatitis as antigen (Fig. 4) . During the acute phase of the illness cell-mediated immunity could be found against both antigens. This became weaker during convalescence and could not be detected by this technique three months after the start of the illness. 
Discussion
The leucocyte migration test of Soborg and Bendixen has been used in man as an in-vitro assay to detect the presence of cellmediated immunity to a variety of test antigens (Bendixen and Soborg, 1969; Becker et al., 1972; Smith et al., 1972) . Inhibition of leucocyte migration in the presence of antigen has been shown to be a good index of the presence of cell-mediated immunity to that antigen (Soborg, 1967) . Stimulation of migration has also been described in this test system and it has been suggested that this represents weak cell-mediated immunity to the test antigen (Soborg, 1968 ). This conclusion, however, is still to be confirmed. In this study we have regarded only inhibition of leucocyte migration as definite evidence for the presence of cell-mediated immunity to the test antigen. By using this test system we have been able to show cellmediated immunity in a number of patients to antigens contained in both the serum and liver of H.A.A.-positive patients. This cell-mediated immunity was found by using both autologous and homologous H. (1972) has postulated that a normal cellular immune response to antigenic determinants of the infective agent responsible for H.A.A.-positive hepatitis is necessary for the production of an acute hepatitis with subsequent recovery and clearance of antigen. However, in the presence of an impaired cellular immune response to these antigens both the infective agent and H.A.A. will persist and the activity of the associated liver cell damage will be less in the patients with the greater impairment of this response. Our results support this hypothesis.
Cell-mediated immunity to the H.A.A.-positive test antigen could be found in only some of the patients with serum antibody to H.A.A., and disappeared during the convalescence of two patients after 9ute hepatitis. This could mean that cellmediated immunity to our test antigens does not persist after hepatitis, or, more likely, that the test as used in this study is of insufficient sensitivity to detect weak cell-mediated immunity.
Other reports of leucocyte migration to varied antigens in liver disease tend to support our results. When H.A.A. concentrated from sera by ultracentrfugation was used as test antigen (Ito et al., 1972) cell-mediated immunity was commonly detected in patients with a history of H.A.A.-positive acute hepatitis but could not be detected in five patients with persistent antigenaemia (four with chronic hepatitis). This again suggests the importance of cell-mediated immunity in the clearance of the infective agent responsible for H.A.A.-positive hepatitis. In another study liver antigen prepared from normal fetal or postmortem liver was used as test antigen (Smith et al., 1972 ) and cell-mediated immunity was definitely found to this antigen in only one of 15 patients with acute hepatitis. This study supports our findings that the cell-mediated immunity found in the present patients is specific for antigens related to the infective agent associated with H.A.A.
This study has thus shown the presence of cell-mediated immunity to antigens related to the infective agent responsible for H.A.A.-positive hepatitis in a number of patients with evidence of earlier contact with this agent. Dudley et al. (1972) postulated that the liver cell damage in H.A.A.-positive patients is related to the T lymphocyte cell-mediated immune response against the associated infective agent and that variations in T lymphocyte function may be responsible for the different clinical courses that can follow contact with this infective agent. Our results support this hypothesis.
